LCN2 and chronic kidney disease: To further confirm that LCN2 directly regulates FGF23 in CKD, we administered murine recombinant LCN2 to Col4a3KO and CPD mice for 8 weeks, from 16 to 23 weeks, using osmotic minipumps.